These data suggest that CCR1 is overexpressed in breast invasive ductal carcinoma (IDC) as compared to adjacent normal tissues, regardless of ER, PR, and HER2 expression status. This evidence concerns the gene ERBB2 and invasive ductal breast carcinoma.